India’s Drugs Controller tightened surveillance on GLP-1-based weight loss medicines as unauthorized generic versions proliferate in retail pharmacies.
Officials flagged counterfeit and off-label sales of molecules popularized for diabetes and obesity treatment.
Regulators ordered state drug inspectors to raid outlets marketing unapproved formulations without prescriptions.
Physicians warned that compounded copies may lack stability testing and accurate dosing.
Legitimate manufacturers must still meet import and clinical trial rules before broad over-the-counter availability.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.newsonair.gov.in/category/national/page/36/?lang=en